Umoya Capital Partners

SANTS Private Higher Education Institution specializes in providing comprehensive teacher education programs. It offers a range of qualifications including a Diploma in Grade R Teaching and Bachelor of Education in Foundation Phase Teaching. The institution caters to the evolving needs of the education sector by offering its courses in a distance learning format supported by online resources. SANTS is committed to addressing educational challenges such as school violence through its curriculum and support services, aiming to equip educators with the skills and knowledge necessary for fostering safe and conducive learning environments.

m4a (Pty) Ltd specializes in the manufacturing of composite and plastics products designed for the utilities networks industry. As an Original Equipment Manufacturer (OEM), the company offers a comprehensive range of products including access chambers, microducts, bundled microducts (multiducts), sub ducts, corrugated pipes, axsCHAMBERS™, cnktCLOSURES™, fibreDUCT™, and fibreCABLE™. These products cater to the telecommunications sector, providing end-to-end solutions for infrastructure needs. m4a (Pty) Ltd is recognized for its innovative approach in developing polymer and composite civil infrastructure solutions. The company holds ISO9001 certification, ensuring high standards in quality management systems.

M4A is an equipment manufacturer of composite and plastics products with a focus on the utilities networks and infrastructure markets.

Brunel Laboratoria is a privately owned pharmaceutical company based in South Africa. The business specializes in the distribution of pharmaceuticals and complementary medicines, along with dispensary consumables. It offers a diverse range of products, including oral health, haircare, eye care products, vitamins and minerals, sun protection, lubricant gels, disinfectants, and probiotics. Brunel operates from a custom-built distribution facility that is fully temperature and access-controlled, allowing for direct delivery of pharmaceutical products from manufacturers to clients without reliance on third-party or wholesale distribution channels.